Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Gastroenterology and Hepatology

• Publication date

  2005-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1542-3565(05)00017-0PMID 16206505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication

  2008cited by this paper
• Branched-Chain Amino Acids : Metabolism , Physiological Function , and Application Branched-Chain Amino Acid Enriched Supplements as Therapy for Liver Disease

  2005cited by this paper
• Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.

  2004cited by this paper
• Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial.

  2003cited by this paper
• Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives.

  2003cited by this paper
• Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

  2003cited by this paper
• Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration.

  2003cited by this paper
• Prognostic value of energy metabolism in patients with viral liver cirrhosis.

  2002cited by this paper
• Regulation of mammalian translation factors by nutrients.

  2002cited by this paper
• Nutrition and survival in patients with liver cirrhosis.

  2001cited by this paper
• Amino Acid Sufficiency and mTOR Regulate p70 S6 Kinase and eIF-4E BP1 through a Common Effector Mechanism*

  1998cited by this paper
• Oral Supplementation with Branched-Chain Amino Acids Improves Survival Rate of Rats with Carbon Tetrachloride-Induced Liver Cirrhosis

  1998cited by this paper
• Identification of high‐ and low‐risk patients before liver transplantation: A prospective cohort study of nutritional and metabolic parameters in 150 patients

  1997cited by this paper
• ESPEN guidelines for nutrition in liver disease and transplantation.

  1997cited by this paper
• Oral supplementation with branched-chain amino acids improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis.

  1996cited by this paper
• Serum albumin level and prognosis in patients with liver cirrhosis-result of branched-chain amino acid granules (BCAA-G) supplement trial

  1995cited by this paper
• Changes in the ratio of branched-chain to aromatic amino acids affect the secretion of albumin in cultured rat hepatocytes.

  1995cited by this paper
• Malnutrition in cirrhosis.

  1995cited by this paper
• Clearance rate of plasma branched-chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis

  1995cited by this paper
• Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. American Society for Parenteral and Enteral Nutrition.

  1993cited by this paper
• [The clinical usefulness of the molar ratio of branched-chain amino acids to tyrosine (BTR) in discriminating stage of chronic liver diseases].

  1992cited by this paper
• Effect of oral supplementation with BCAA-G on the prognosis of liver cirrhosis

  1992cited by this paper
• Effect of branched-chain amino acid(BCAA) enriched-nutrient mixture on albumin metabolism in cirrhotic patients.

  1991cited by this paper
• Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial.

  1990cited by this paper
• Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis.

  1989cited by this paper
• Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis

  1989cited by this paper
• Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake.

  1989cited by this paper
• VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition.

  1986cited by this paper
• Parenteral and enteral hyperalimentation

  1986cited by this paper
• Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis.

  1985cited by this paper
• Prognostic Value of Child‐Turcotte Criteria in Medically Treated Cirrhosis

  1984cited by this paper
• Comparison of the Effects of Hepatic‐Aid and a Casein Modular Diet on Enceph‐alopathy, Plasma Amino Acids, and Nitrogen Balance in Cirrhotic Patients

  1983cited by this paper
• The effect of normalization of plasma amino acids on hepatic encephalopathy in man.

  1976cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper

• Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy.

  2026cites this paper
• Current management strategies for sarcopenia and frailty in cirrhosis: Missing link in transplant candidacy

  2026cites this paper
• Optimizing Nutrition to Counter Sarcopenia in Hepatocellular Carcinoma: A Narrative Review of Mechanisms, Clinical Consequences, and Supportive Therapeutic Options

  2026cites this paper
• Association of the protein-sodium dietary index with the incidence of clinical decompensation in patients with liver cirrhosis.

  2025cites this paper
• Branched-Chain Amino Acid Metabolic Reprogramming and Cancer: Molecular Mechanisms, Immune Regulation, and Precision Targeting

  2025cites this paper
• Serum tyrosine level is an independent factor for hepatocellular carcinoma development and mortality in patients with chronic liver disease

  2025cites this paper
• Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review.

  2025cites this paper
• Isoleucine Enriched Branched-Chain Amino Acid Supplement Improves Glucose and Insulin Sensitivity in Healthy College-Age Males but Not in Females

  2025cites this paper
• Plant Protein-based Diet Fortified With Isoleucine, Leucine, and Valine Mitigates the Carbon Tetrachloride-induced Damage on Caspase-3 Gene Expression and Tissue Architecture: Histomorphological and Immunohistochemical Approaches.

  2025cites this paper
• Gut microbiota and nutritional interventions in alcohol-associated liver disease: Mechanisms and therapeutic advances.

  2025cites this paper
• Relationship between vitamin D deficiency and the development of hepatic encephalopathy among patients with liver cirrhosis

  2025cites this paper
• Hepatitis C Virus Clearance Is Associated With the Improvement of the Branched‐Chain Amino Acid to Tyrosine Ratio (BTR) of Patients With Mild‐To‐Advanced Fibrosis

  2025cites this paper
• Nutritional Management of Liver Failure in the Intensive Care Unit

  2025cites this paper
• Multidisciplinary approach to malnutrition and physical frailty in patients with decompensated cirrhosis

  2025cites this paper
• Pharmacotherapy for Cirrhosis in Japan

  2025cites this paper
• Impact of Serum Albumin Levels on Prognosis and Recurrence in Patients with Hepatocellular Carcinoma

  2025cites this paper
• Current advances in the management of hepatic encephalopathy: an updated and critical review

  2025cites this paper
• Impact of the prognostic nutritional index on the recompensation of patients with decompensated primary biliary cholangitis

  2025cites this paper
• Branched-Chain Amino Acid Supplementation and Clinical Outcomes in Liver Cirrhosis: A Propensity Score-Matched Multicenter Retrospective Cohort Study

  2025cites this paper
• Prospective randomized, placebo-controlled study: role of branched-chain amino acids infusion as adjunct therapy post-liver surgery for patients in the intensive care unit

  2025influential citation
• Optimizing muscle preservation during weight loss in patients with cirrhosis: A pilot study comparing continuous energy restriction to alternate‐day modified fasting for weight loss in patients with obesity and non‐alcoholic cirrhosis of the liver

  2024cites this paper
• Alcohol-associated liver disease: Emerging therapeutic strategies

  2024influential citation
• Association of Serum 25-Hydroxyvitamin D Level with the Grades of Hepatic Encephalopathy in Cirrhotic Patients

  2024cites this paper
• Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis

  2024cites this paper
• Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy

  2024cites this paper
• Possible pathogenetic role of ammonia in liver cirrhosis without hyperammonemia of venous blood: The so‐called latency period of abnormal ammonia metabolism

  2024cites this paper
• S2k-Leitlinie Klinische Ernährung in der Hepatologie

  2024cites this paper
• Nutritional counseling improves mortality and prevents hepatic encephalopathy in patients with alcohol‐associated liver disease

  2024cites this paper
• Body Composition in Chronic Liver Disease

  2024cites this paper
• Comprehensive analysis of peripheral blood free amino acids in MASLD: the impact of glycine-serine-threonine metabolism

  2024cites this paper
• Positive impact of obesity on the prognosis of liver cirrhosis

  2024cites this paper
• Differences in branched-chain amino acid to tyrosine ratio (BTR) among etiologies of chronic liver disease progression compared to healthy adults.

  2024cites this paper
• Effect of a 12-week nutritional intervention in the food intake of patients on the waiting list for liver transplantation: A secondary analysis of a randomized controlled trial.

  2024cites this paper
• High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis Model

  2024cites this paper
• Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease

  2023cites this paper
• Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases

  2023cites this paper
• Sarcopenia in end-stage liver disease and after liver transplantation.

  2023cites this paper
• Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties

  2023cites this paper
• Effect of dietary branched chain amino acids on liver related mortality: Results from a large cohort of North American patients with advanced HCV infection

  2023cites this paper
• Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease

  2023influential citation
• Dietary protein intake and mortality among survivors of liver cirrhosis: a prospective cohort study

  2023cites this paper
• Principles of Nutritional Management in Patients with Liver Dysfunction—A Narrative Review

  2023cites this paper
• The efficacy of branched-chain amino acid granules to restore phagocytic activity in cirrhosis patients, a randomized controlled trial

  2023cites this paper
• Sarcopenia and Frailty in Cirrhosis: Assessment and Management.

  2023cites this paper
• BRANCHED CHAINED AMINO ACIDS ENRICHED BAR AND CHRONIC LIVER DISEASE: A CASE STUDY

  2023cites this paper
• Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy

  2023cites this paper
• [ESPEN Practical Guideline: Clinical nutrition in liver disease].

  2022cites this paper
• Branched Chain Amino Acids Promote ATP Production Via Translocation of Glucose Transporters

  2022cites this paper
• Hepatoprotective Effect of Oyster Peptide on Alcohol-Induced Liver Disease in Mice

  2022cites this paper
• When is enteral nutrition indicated?

  2022cites this paper
• Favorable and harmful effects of branched-chain amino acid administration in patients with liver cirrhosis: effects on hepatic encephalopathy and ammonia metabolism

  2022cites this paper
• Serum Amino Acids Imbalance in Canine Chronic Hepatitis: Results in 16 Dogs

  2022cites this paper
• Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

  2022cites this paper
• Systematic review with meta‐analysis: Branched‐chain amino acid supplementation in liver disease

  2022cites this paper
• Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients.

  2022cites this paper
• Symptom Management in Patients with Cirrhosis: a Practical Guide

  2022cites this paper
• Role of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis

  2022cites this paper
• Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy

  2022cites this paper
• Current Medical Treatment for Alcohol-Associated Liver Disease.

  2022cites this paper
• Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis

  2022cites this paper
• Branched-chain amino acids supplementation has beneficial effects on the progression of liver cirrhosis: A meta-analysis

  2022cites this paper
• New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease

  2022cites this paper
• Fatty liver and risk of dementia NAFLD increases a risk of stroke DPP-4 inhibitor-specific biomarkers in NAFLD LPS promotes HCC by NETs formation via TLR4 CLIF-SOFA score and sepsis

  2022cites this paper
• Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis.

  2022cites this paper
• The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment

  2022cites this paper
• Analysis of adverse events leading to dose reduction/interruption of lenvatinib treatment in patients with Child-Pugh B unresectable hepatocellular carcinoma

  2022cites this paper
• Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions

  2022cites this paper
• Branched chain amino acid-to-tyrosine ratio: not only an indicator of the amino acid imbalance

  2022cites this paper
• Exploration of the Protective Mechanism of Naringin in the Acetaminophen-Induced Hepatic Injury by Metabolomics

  2022cites this paper
• Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy

  2022cites this paper
• Recent Progress of Nutritional Management for Liver Cirrhosis.

  2022cites this paper
• Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

  2021cites this paper
• Interorgan Metabolism of Amino Acids in Human Health and Disease.

  2021cites this paper
• Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan

  2021cites this paper
• Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial

  2021cites this paper
• Sarcopenia and frailty in decompensated cirrhosis.

  2021cites this paper
• Relationship between symptoms and both stage of change in adopting a healthy life style and quality of life in patients with liver cirrhosis: a cross-sectional study

  2021cites this paper
• A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models

  2021cites this paper
• Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Impact of Liver and Pancreas Diseases on Nutritional Status

  2021cites this paper
• Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy

  2021influential citation
• NUTRITION IN PATIENTS WITH CHRONIC LIVER DISEASE (A MONTANO-LOZA, SECTION

  2021cites this paper
• Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic Encephalopathy in HCV-Related Liver Cirrhosis

  2021cites this paper
• Branched-chain amino acids protect the liver from cirrhotic injury via suppression of activation of lipopolysaccharide-binding protein, toll-like receptor 4, and signal transducer and activator of transcription 3, as well as Enterococcus faecalis translocation.

  2021cites this paper
• Emerging Treatment Options for Sarcopenia in Chronic Liver Disease

  2021cites this paper
• Sarcopenia in Children With End‐Stage Liver Disease on the Transplant Waiting List

  2021cites this paper
• A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy

  2021cites this paper
• Malnutrition in Patients with Liver Cirrhosis

  2021cites this paper
• Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker

  2021cites this paper
• Treatment of Muscle Cramps in Patients With Cirrhosis of Liver: A Systematic Review.

  2021cites this paper
• Diagnosis and Management of Hepatic Encephalopathy

  2021cites this paper
• Fatty Liver Disease: Diagnosis and Stratification.

  2021cites this paper
• Supplementation with Branched-Chain Amino Acids Induces Unexpected Deleterious Effects on Astrocyte Survival and Intracellular Metabolism with or without Hyperammonemia: A Preliminary In Vitro Study

  2021cites this paper
• Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant.

  2021cites this paper
• Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience

  2021cites this paper
• NUTRITIONAL THERAPY TO CIRRHOTIC PATIENTS ON TRANSPLANTATION WAITING LISTS

  2021cites this paper
• Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review.

  2021cites this paper
• Usefulness of nutritional therapy recommended in the Japanese Society of Gastroenterology/Japan Society of Hepatology evidence-based clinical practice guidelines for liver cirrhosis 2020

  2021cites this paper
• SHORT-TERM EFFECT OF WHEY PROTEIN SUPPLEMENTATION ON THE QUALITY OF LIFE OF PATIENTS WAITING FOR LIVER TRANSPLANTATION: A DOUBLE BLINDED RANDOMIZED CLINICAL TRIAL

  2021cites this paper
• Elevated serum tyrosine concentration is associated with a poor prognosis among patients with liver cirrhosis

  2021cites this paper